Long-term function of a novel autologous transcatheter pulmonary heart valve implant in an adult animal model

Current heart valve implants entail major disadvantages in the treatment for younger patients or those with congenital heart defects. In vitro testing was performed in a Pulse Duplicator by the Canadian company ViVitro Labs Inc. equipped with flow and pressure sensors that is certified according to ISO-standard 5840 simulating conditions in the human heart. In vitro tests in a pulse duplicator showed compliance with regulatory requirements in terms of valve opening and insufficiency.

Go to article »

Join over 5000 cardiovascular device professionals who receive our testing and engineering insights and tips every month.